Philips CEO on 2Q Earnings, M&A, Personal Health Business

The transcript covers Philips' Q2 performance, highlighting a 4% growth in health technology and an 8% increase in order intake. It discusses leadership changes in the personal health business and plans for growth. Philips' M&A strategy, including the acquisition of Spectranetics, is outlined, along with financial strategies like share buybacks. The company plans to divest its Philips Lighting shares to focus on health tech. Rumors of activist investors are addressed, and the impact of US healthcare policy on Philips' operations is discussed.

What is the significance of the company's capital allocation policy?

What are the expectations for profit improvement in the coming years?

How does Philips plan to address the concerns of its customers regarding the Accountable Care Act?